Hydromer Enters Into Medical Coating Licenses With Two International Medical Device Companies
February 25 2013 - 10:24AM
Marketwired
Hydromer, Inc. (OTC Pink: HYDI) announced that during the last 30
days it entered into License Agreements with two non-USA based
medical device manufacturers.
In January 2013, an Agreement was entered with a Chinese Medical
Device company licensing the use of a proprietary Hydromer® medical
coating for use on Nelaton Urinary Self-Catheters. The Chinese
Medical Device company intends to manufacture the catheters in
China and sell the coated product globally.
In early February 2013, an Agreement was entered with a United
Arab Emirates based Medical Device company licensing the use of two
proprietary Hydromer® medical coatings for use on PTCA/PTA
Catheters. This UAE based Medical Device company intends to market
their precision vascular access catheters in the Middle East and
Global markets.
"Our focus in the lucrative and rapidly growing Chinese Medical
Device market is gaining momentum as more Chinese companies are
evaluating our coatings which have previous approvals with
international regulatory agencies such as the US FDA, SFDA, CE/ISO,
Japanese and others," commented Martin von Dyck, Executive Vice
President of Hydromer, Inc., adding, "We are quite proud with our
new UAE relationship, who selected Hydromer coatings based on our
superior performance, previous regulatory approvals and high
certainty of preventing particulate contamination in the blood
stream. Hydromer coatings continually pass the USP 788 Particulate
Matter in Injections test and the challenging Japanese Ministry of
Health's Eluate test as well as the stringent ISO 8536-4 and
China's GB/T14233.1 tests for reducing oxidizable matter. Passing
all of these required tests ensures that Hydromer medical coatings
continue to be prized globally as a premium biocompatible value
added product."
About Hydromer, Inc.: Hydromer, Inc. is a bio-technology-based
company involved in the research and development, manufacture,
contract coating and commercialization of specialized polymer and
hydrogel products for medical device, animal health, cosmetic,
personal care, and industrial uses. These technologies include
Hydromer lubricious / anti-microbial / anti-thrombogenic / cell
anti-mitosis / cell growth enhancing coatings for the medical
marketplace.
For additional information please visit the following Web-sites:
www.hydromer.com
Hydromer ® is a registered trademark of Hydromer, Inc.
Contact: Martin von Dyck Executive Vice President 35 Industrial
Parkway Branchburg, NJ. USA Phone 908 722 5000 www.hydromer.com
Hydromer (CE) (USOTC:HYDI)
Historical Stock Chart
From Sep 2024 to Oct 2024
Hydromer (CE) (USOTC:HYDI)
Historical Stock Chart
From Oct 2023 to Oct 2024